CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-14). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2569 · Search date 2026-08-14 · Methodology v0.7

HydraFacial Clarifying,
does it really help with Clear or almost-clear improvement of mild-to-moderate acne?

30-Second Summary
C
Evidence Grade C · 46 · Safety caution
Acne improved before versus after, but the procedure’s own comparative effect cannot be estimated without a concurrent control.
Erythema, edema, stinging, and itching were common; one severe tingling event resolved before the next treatment. Discuss active skin infection, herpes history, or recent isotretinoin use with a clinician before treatment.
What the
research shows
The grade is C. In a 20-person single-arm study, clear or almost-clear status rose from 4/20 (20%) to 13/20 (65%) by investigator rating and from 1/20 (5%) to 11/20 (55%) by patient rating. With no concurrent control, natural fluctuation, background care, and expectation could not be separated, and no between-group effect or confidence interval can be calculated. Open ratings and a 20-person sample are separate limitations; this gives C with 46 points.
What the
ads claim
The procedure genuinely combined cleansing, peeling, suction, infused solutions, and blue LED. Before-after photographs and scores cannot establish superiority to no procedure or standard acne treatment.
*

Useful facts when choosing a product

  • Each session combined cleansing and peeling, suction extraction, glycolic and salicylic solutions, eight minutes of blue LED, and hydration.
  • Eighteen of 20 completed all six treatments; two completed five.
  • Moderate erythema and edema and transient stinging or itching occurred; one severe tingling event resolved before the next treatment.
Gap Measurement · Verdict 2569 · C 46
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Storgard R, Mauricio-Lee J, Mauricio T et al. enrolled 20 participants at two US sites for six treatments every two weeks over 12 weeks. Eighteen completed six treatments and two completed five; last observation carried forward was used for missing data. There was no concurrent control or randomization. The paper states, “FUNDING: No funding was provided for this article,” and separately discloses Dr. Kwala as an employee of The Hydrafacial Company. There was no registration number or manufacturer-sponsor registry record, so study sponsorship could not be confirmed.

02

Why this is classified as C (46)

No concurrent control makes comparative magnitude unknowable, giving EX. Separately, the 20-person sample and open subjective investigator and patient ratings establish B2. The paper states no funding, but a company employee was a coauthor and study sponsorship was unconfirmed, so independence is I1; the score remains C with 46 points.

Counterpoint. This is an exploratory improvement signal, not a confirmed comparative treatment effect.

Rejudgment record. Cross-check applied — We directly checked analysis and completion counts, missing-data handling, before-after proportions, lack of control, open ratings, funding, and employee disclosure in the full article.

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeEXThe clinical size of the effect could not be judged

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
More participants clear or almost clear after six treatmentsCThe before-after proportion increased, but there was no control group.
Superior to standard acne treatment?No direct comparison was performed.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Two-site prospective open-label single-arm before-after study5Paper states no funding; a Hydrafacial Company employee was a coauthor; study sponsorship unconfirmedInvestigator and patient GASS clear or almost clear at 12 weeksInvestigator 4/20 to 13/20, P=.0027; patient 1/20 to 11/20, P=.0016; no concurrent control or effect CIUncontrolled exploratory before-after evidence
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-14).

Storgard R, Mauricio-Lee J, Mauricio T, Zaiac M, Karnik J. Efficacy and Tolerability of HydraFacial Clarifying Treatment Series in the Treatment of Active Acne Vulgaris. J Clin Aesthet Dermatol. 2022;15(12):42-46. PMID: 36569524. PMCID: PMC9762628.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-14 · Corrections: none

Cite this verdict

HydraFacial Clarifying x improvement of mild-to-moderate acne Evidence Grade C card
[Chamgap] HydraFacial Clarifying x improvement of mild-to-moderate acne — Evidence Grade C·46. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/hydrafacial-clarifying-mild-moderate-acne-clearance/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.